Loading...
Treatment of chronic hepatitis B patients with tyrosine-methionine-aspartate-aspartate mutations
Lamivudine is an antiviral used for the treatment of chronic hepatitis B. Several studies have reported various mutations that are induced by lamivudine therapy. These mutations in the tyrosine-methionine-aspartate-aspartate (YMDD) motif are necessary and sufficient to confer high-level lamivudine r...
Na minha lista:
| Udgivet i: | World J Gastroenterol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Baishideng Publishing Group Inc
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4722003/ https://ncbi.nlm.nih.gov/pubmed/26819537 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v22.i4.1727 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|